nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Temsirolimus—kidney cancer	0.0891	0.144	CbGbCtD
Perhexiline—CYP3A4—Everolimus—kidney cancer	0.0839	0.136	CbGbCtD
Perhexiline—CYP3A4—Temsirolimus—kidney cancer	0.0566	0.0919	CbGbCtD
Perhexiline—CYP2B6—Sorafenib—kidney cancer	0.0562	0.0912	CbGbCtD
Perhexiline—CYP2D6—Pazopanib—kidney cancer	0.0468	0.0759	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—kidney cancer	0.0341	0.0553	CbGbCtD
Perhexiline—CYP2D6—Erlotinib—kidney cancer	0.0334	0.0542	CbGbCtD
Perhexiline—CYP3A4—Pazopanib—kidney cancer	0.0298	0.0483	CbGbCtD
Perhexiline—CYP2D6—Sorafenib—kidney cancer	0.0271	0.044	CbGbCtD
Perhexiline—CYP2D6—Vinblastine—kidney cancer	0.0268	0.0435	CbGbCtD
Perhexiline—CYP3A4—Erlotinib—kidney cancer	0.0212	0.0344	CbGbCtD
Perhexiline—CYP3A4—Paclitaxel—kidney cancer	0.0194	0.0315	CbGbCtD
Perhexiline—CYP3A4—Sorafenib—kidney cancer	0.0173	0.028	CbGbCtD
Perhexiline—CYP3A4—Vinblastine—kidney cancer	0.017	0.0277	CbGbCtD
Perhexiline—CYP3A4—Vincristine—kidney cancer	0.0168	0.0272	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—kidney cancer	0.0165	0.0267	CbGbCtD
Perhexiline—CYP3A4—Sunitinib—kidney cancer	0.014	0.0227	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—kidney cancer	0.0105	0.017	CbGbCtD
Perhexiline—CPT2—nephron tubule—kidney cancer	0.00657	0.0901	CbGeAlD
Perhexiline—CPT1A—renal system—kidney cancer	0.00629	0.0863	CbGeAlD
Perhexiline—CPT1A—kidney—kidney cancer	0.00608	0.0834	CbGeAlD
Perhexiline—CPT2—renal system—kidney cancer	0.00597	0.0819	CbGeAlD
Perhexiline—CPT2—kidney—kidney cancer	0.00577	0.0792	CbGeAlD
Perhexiline—CPT1A—gonad—kidney cancer	0.00564	0.0774	CbGeAlD
Perhexiline—CPT2—cortex of kidney—kidney cancer	0.00562	0.0771	CbGeAlD
Perhexiline—CPT2—gonad—kidney cancer	0.00535	0.0735	CbGeAlD
Perhexiline—CPT2—cardiac atrium—kidney cancer	0.00535	0.0734	CbGeAlD
Perhexiline—CYP3A4—urine—kidney cancer	0.0048	0.0658	CbGeAlD
Perhexiline—CYP2D6—urine—kidney cancer	0.00472	0.0647	CbGeAlD
Perhexiline—CYP2B6—nephron tubule—kidney cancer	0.00171	0.0234	CbGeAlD
Perhexiline—CYP2B6—renal system—kidney cancer	0.00155	0.0213	CbGeAlD
Perhexiline—CYP2B6—kidney—kidney cancer	0.0015	0.0206	CbGeAlD
Perhexiline—CYP2B6—gonad—kidney cancer	0.00139	0.0191	CbGeAlD
Perhexiline—CYP3A4—renal system—kidney cancer	0.00117	0.0161	CbGeAlD
Perhexiline—CYP2D6—renal system—kidney cancer	0.00115	0.0158	CbGeAlD
Perhexiline—CYP3A4—kidney—kidney cancer	0.00113	0.0156	CbGeAlD
Perhexiline—CYP2D6—kidney—kidney cancer	0.00112	0.0153	CbGeAlD
Perhexiline—Weight decreased—Sunitinib—kidney cancer	0.000897	0.00428	CcSEcCtD
Perhexiline—Gait disturbance—Capecitabine—kidney cancer	0.000893	0.00426	CcSEcCtD
Perhexiline—Flushing—Everolimus—kidney cancer	0.000882	0.00421	CcSEcCtD
Perhexiline—Neuropathy peripheral—Sunitinib—kidney cancer	0.000867	0.00414	CcSEcCtD
Perhexiline—Anorexia—Temsirolimus—kidney cancer	0.000865	0.00413	CcSEcCtD
Perhexiline—Muscular weakness—Vincristine—kidney cancer	0.000856	0.00409	CcSEcCtD
Perhexiline—Shock—Pazopanib—kidney cancer	0.000841	0.00402	CcSEcCtD
Perhexiline—Hyperhidrosis—Pazopanib—kidney cancer	0.000827	0.00395	CcSEcCtD
Perhexiline—Insomnia—Temsirolimus—kidney cancer	0.000821	0.00392	CcSEcCtD
Perhexiline—Anorexia—Pazopanib—kidney cancer	0.000815	0.00389	CcSEcCtD
Perhexiline—Hepatitis—Sunitinib—kidney cancer	0.000794	0.00379	CcSEcCtD
Perhexiline—Hypoglycaemia—Paclitaxel—kidney cancer	0.00079	0.00377	CcSEcCtD
Perhexiline—Decreased appetite—Temsirolimus—kidney cancer	0.000789	0.00377	CcSEcCtD
Perhexiline—Fatigue—Temsirolimus—kidney cancer	0.000783	0.00374	CcSEcCtD
Perhexiline—Tremor—Everolimus—kidney cancer	0.000775	0.0037	CcSEcCtD
Perhexiline—Insomnia—Pazopanib—kidney cancer	0.000774	0.00369	CcSEcCtD
Perhexiline—Paraesthesia—Pazopanib—kidney cancer	0.000768	0.00367	CcSEcCtD
Perhexiline—Flushing—Sorafenib—kidney cancer	0.000766	0.00366	CcSEcCtD
Perhexiline—Weight decreased—Vincristine—kidney cancer	0.000759	0.00362	CcSEcCtD
Perhexiline—Hepatitis—Dactinomycin—kidney cancer	0.000752	0.00359	CcSEcCtD
Perhexiline—Decreased appetite—Pazopanib—kidney cancer	0.000743	0.00355	CcSEcCtD
Perhexiline—Gastrointestinal pain—Temsirolimus—kidney cancer	0.000742	0.00354	CcSEcCtD
Perhexiline—Syncope—Everolimus—kidney cancer	0.000742	0.00354	CcSEcCtD
Perhexiline—Fatigue—Pazopanib—kidney cancer	0.000737	0.00352	CcSEcCtD
Perhexiline—Flushing—Sunitinib—kidney cancer	0.000737	0.00352	CcSEcCtD
Perhexiline—Neuropathy peripheral—Vincristine—kidney cancer	0.000733	0.0035	CcSEcCtD
Perhexiline—Loss of consciousness—Everolimus—kidney cancer	0.000727	0.00347	CcSEcCtD
Perhexiline—Ataxia—Paclitaxel—kidney cancer	0.000725	0.00346	CcSEcCtD
Perhexiline—Convulsion—Vinblastine—kidney cancer	0.00072	0.00344	CcSEcCtD
Perhexiline—Abdominal pain—Temsirolimus—kidney cancer	0.000718	0.00343	CcSEcCtD
Perhexiline—Sweating—Vincristine—kidney cancer	0.000717	0.00342	CcSEcCtD
Perhexiline—Convulsion—Everolimus—kidney cancer	0.000717	0.00342	CcSEcCtD
Perhexiline—Syncope—Erlotinib—kidney cancer	0.000716	0.00342	CcSEcCtD
Perhexiline—Loss of consciousness—Erlotinib—kidney cancer	0.000702	0.00335	CcSEcCtD
Perhexiline—Gastrointestinal pain—Pazopanib—kidney cancer	0.000699	0.00334	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—kidney cancer	0.000698	0.00333	CcSEcCtD
Perhexiline—Neuropathy peripheral—Gemcitabine—kidney cancer	0.000696	0.00332	CcSEcCtD
Perhexiline—Sweating—Gemcitabine—kidney cancer	0.00068	0.00325	CcSEcCtD
Perhexiline—Muscular weakness—Paclitaxel—kidney cancer	0.00068	0.00325	CcSEcCtD
Perhexiline—Abdominal pain—Pazopanib—kidney cancer	0.000676	0.00323	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—kidney cancer	0.000668	0.00319	CcSEcCtD
Perhexiline—Shock—Everolimus—kidney cancer	0.000664	0.00317	CcSEcCtD
Perhexiline—Hyperhidrosis—Everolimus—kidney cancer	0.000653	0.00312	CcSEcCtD
Perhexiline—Asthenia—Temsirolimus—kidney cancer	0.000651	0.00311	CcSEcCtD
Perhexiline—Anorexia—Vinblastine—kidney cancer	0.000646	0.00308	CcSEcCtD
Perhexiline—Syncope—Sorafenib—kidney cancer	0.000644	0.00308	CcSEcCtD
Perhexiline—Anorexia—Everolimus—kidney cancer	0.000644	0.00307	CcSEcCtD
Perhexiline—Shock—Erlotinib—kidney cancer	0.000641	0.00306	CcSEcCtD
Perhexiline—Diplopia—Capecitabine—kidney cancer	0.000633	0.00302	CcSEcCtD
Perhexiline—Loss of consciousness—Sorafenib—kidney cancer	0.000631	0.00301	CcSEcCtD
Perhexiline—Anorexia—Erlotinib—kidney cancer	0.000621	0.00297	CcSEcCtD
Perhexiline—Asthenia—Pazopanib—kidney cancer	0.000614	0.00293	CcSEcCtD
Perhexiline—Insomnia—Everolimus—kidney cancer	0.000611	0.00292	CcSEcCtD
Perhexiline—Paraesthesia—Vinblastine—kidney cancer	0.000609	0.00291	CcSEcCtD
Perhexiline—Paraesthesia—Everolimus—kidney cancer	0.000606	0.00289	CcSEcCtD
Perhexiline—Weight decreased—Paclitaxel—kidney cancer	0.000603	0.00288	CcSEcCtD
Perhexiline—Dizziness—Temsirolimus—kidney cancer	0.0006	0.00287	CcSEcCtD
Perhexiline—Convulsion—Sunitinib—kidney cancer	0.000599	0.00286	CcSEcCtD
Perhexiline—Ataxia—Capecitabine—kidney cancer	0.000595	0.00284	CcSEcCtD
Perhexiline—Insomnia—Erlotinib—kidney cancer	0.000589	0.00281	CcSEcCtD
Perhexiline—Decreased appetite—Vinblastine—kidney cancer	0.000589	0.00281	CcSEcCtD
Perhexiline—Decreased appetite—Everolimus—kidney cancer	0.000587	0.0028	CcSEcCtD
Perhexiline—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000582	0.00278	CcSEcCtD
Perhexiline—Fatigue—Everolimus—kidney cancer	0.000582	0.00278	CcSEcCtD
Perhexiline—Vomiting—Temsirolimus—kidney cancer	0.000577	0.00276	CcSEcCtD
Perhexiline—Shock—Sorafenib—kidney cancer	0.000577	0.00275	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—kidney cancer	0.000576	0.00275	CcSEcCtD
Perhexiline—Rash—Temsirolimus—kidney cancer	0.000572	0.00273	CcSEcCtD
Perhexiline—Dermatitis—Temsirolimus—kidney cancer	0.000572	0.00273	CcSEcCtD
Perhexiline—Headache—Temsirolimus—kidney cancer	0.000569	0.00272	CcSEcCtD
Perhexiline—Decreased appetite—Erlotinib—kidney cancer	0.000566	0.0027	CcSEcCtD
Perhexiline—Dizziness—Pazopanib—kidney cancer	0.000566	0.0027	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—kidney cancer	0.000562	0.00268	CcSEcCtD
Perhexiline—Fatigue—Erlotinib—kidney cancer	0.000562	0.00268	CcSEcCtD
Perhexiline—Anorexia—Sorafenib—kidney cancer	0.000559	0.00267	CcSEcCtD
Perhexiline—Muscular weakness—Capecitabine—kidney cancer	0.000558	0.00266	CcSEcCtD
Perhexiline—Shock—Sunitinib—kidney cancer	0.000555	0.00265	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vinblastine—kidney cancer	0.000554	0.00265	CcSEcCtD
Perhexiline—Gastrointestinal pain—Everolimus—kidney cancer	0.000552	0.00264	CcSEcCtD
Perhexiline—Vomiting—Pazopanib—kidney cancer	0.000544	0.0026	CcSEcCtD
Perhexiline—Rash—Pazopanib—kidney cancer	0.000539	0.00257	CcSEcCtD
Perhexiline—Nausea—Temsirolimus—kidney cancer	0.000539	0.00257	CcSEcCtD
Perhexiline—Dermatitis—Pazopanib—kidney cancer	0.000539	0.00257	CcSEcCtD
Perhexiline—Anorexia—Sunitinib—kidney cancer	0.000538	0.00257	CcSEcCtD
Perhexiline—Abdominal pain—Vinblastine—kidney cancer	0.000536	0.00256	CcSEcCtD
Perhexiline—Headache—Pazopanib—kidney cancer	0.000536	0.00256	CcSEcCtD
Perhexiline—Abdominal pain—Everolimus—kidney cancer	0.000534	0.00255	CcSEcCtD
Perhexiline—Gastrointestinal pain—Erlotinib—kidney cancer	0.000533	0.00254	CcSEcCtD
Perhexiline—Abdominal pain—Erlotinib—kidney cancer	0.000515	0.00246	CcSEcCtD
Perhexiline—Insomnia—Sunitinib—kidney cancer	0.00051	0.00244	CcSEcCtD
Perhexiline—Decreased appetite—Sorafenib—kidney cancer	0.00051	0.00243	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—kidney cancer	0.000509	0.00243	CcSEcCtD
Perhexiline—Nausea—Pazopanib—kidney cancer	0.000508	0.00243	CcSEcCtD
Perhexiline—Paraesthesia—Sunitinib—kidney cancer	0.000506	0.00242	CcSEcCtD
Perhexiline—Convulsion—Vincristine—kidney cancer	0.000506	0.00242	CcSEcCtD
Perhexiline—Fatigue—Sorafenib—kidney cancer	0.000505	0.00241	CcSEcCtD
Perhexiline—Flushing—Paclitaxel—kidney cancer	0.000495	0.00236	CcSEcCtD
Perhexiline—Weight decreased—Capecitabine—kidney cancer	0.000495	0.00236	CcSEcCtD
Perhexiline—Decreased appetite—Sunitinib—kidney cancer	0.00049	0.00234	CcSEcCtD
Perhexiline—Asthenia—Vinblastine—kidney cancer	0.000486	0.00232	CcSEcCtD
Perhexiline—Fatigue—Sunitinib—kidney cancer	0.000486	0.00232	CcSEcCtD
Perhexiline—Asthenia—Everolimus—kidney cancer	0.000484	0.00231	CcSEcCtD
Perhexiline—Gastrointestinal pain—Sorafenib—kidney cancer	0.000479	0.00229	CcSEcCtD
Perhexiline—Neuropathy peripheral—Capecitabine—kidney cancer	0.000478	0.00228	CcSEcCtD
Perhexiline—Asthenia—Erlotinib—kidney cancer	0.000467	0.00223	CcSEcCtD
Perhexiline—Urticaria—Sorafenib—kidney cancer	0.000466	0.00222	CcSEcCtD
Perhexiline—Decreased appetite—Dactinomycin—kidney cancer	0.000464	0.00222	CcSEcCtD
Perhexiline—Abdominal pain—Sorafenib—kidney cancer	0.000463	0.00221	CcSEcCtD
Perhexiline—Gastrointestinal pain—Sunitinib—kidney cancer	0.000461	0.0022	CcSEcCtD
Perhexiline—Hyperhidrosis—Vincristine—kidney cancer	0.000461	0.0022	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—kidney cancer	0.00046	0.0022	CcSEcCtD
Perhexiline—Tension—Paclitaxel—kidney cancer	0.000456	0.00218	CcSEcCtD
Perhexiline—Anorexia—Vincristine—kidney cancer	0.000455	0.00217	CcSEcCtD
Perhexiline—Nervousness—Paclitaxel—kidney cancer	0.000451	0.00215	CcSEcCtD
Perhexiline—Dizziness—Vinblastine—kidney cancer	0.000448	0.00214	CcSEcCtD
Perhexiline—Dizziness—Everolimus—kidney cancer	0.000447	0.00213	CcSEcCtD
Perhexiline—Abdominal pain—Sunitinib—kidney cancer	0.000446	0.00213	CcSEcCtD
Perhexiline—Hepatitis—Capecitabine—kidney cancer	0.000438	0.00209	CcSEcCtD
Perhexiline—Hyperhidrosis—Gemcitabine—kidney cancer	0.000438	0.00209	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000437	0.00208	CcSEcCtD
Perhexiline—Tremor—Paclitaxel—kidney cancer	0.000435	0.00208	CcSEcCtD
Perhexiline—Insomnia—Vincristine—kidney cancer	0.000431	0.00206	CcSEcCtD
Perhexiline—Anorexia—Gemcitabine—kidney cancer	0.000431	0.00206	CcSEcCtD
Perhexiline—Vomiting—Vinblastine—kidney cancer	0.000431	0.00206	CcSEcCtD
Perhexiline—Dizziness—Erlotinib—kidney cancer	0.000431	0.00206	CcSEcCtD
Perhexiline—Vomiting—Everolimus—kidney cancer	0.000429	0.00205	CcSEcCtD
Perhexiline—Paraesthesia—Vincristine—kidney cancer	0.000428	0.00205	CcSEcCtD
Perhexiline—Rash—Everolimus—kidney cancer	0.000426	0.00203	CcSEcCtD
Perhexiline—Dermatitis—Everolimus—kidney cancer	0.000425	0.00203	CcSEcCtD
Perhexiline—Headache—Vinblastine—kidney cancer	0.000425	0.00203	CcSEcCtD
Perhexiline—Headache—Everolimus—kidney cancer	0.000423	0.00202	CcSEcCtD
Perhexiline—Abdominal pain—Dactinomycin—kidney cancer	0.000422	0.00202	CcSEcCtD
Perhexiline—Asthenia—Sorafenib—kidney cancer	0.000421	0.00201	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—kidney cancer	0.000418	0.002	CcSEcCtD
Perhexiline—Syncope—Paclitaxel—kidney cancer	0.000416	0.00199	CcSEcCtD
Perhexiline—Decreased appetite—Vincristine—kidney cancer	0.000415	0.00198	CcSEcCtD
Perhexiline—Vomiting—Erlotinib—kidney cancer	0.000414	0.00198	CcSEcCtD
Perhexiline—Fatigue—Vincristine—kidney cancer	0.000411	0.00196	CcSEcCtD
Perhexiline—Rash—Erlotinib—kidney cancer	0.000411	0.00196	CcSEcCtD
Perhexiline—Dermatitis—Erlotinib—kidney cancer	0.00041	0.00196	CcSEcCtD
Perhexiline—Insomnia—Gemcitabine—kidney cancer	0.000409	0.00195	CcSEcCtD
Perhexiline—Headache—Erlotinib—kidney cancer	0.000408	0.00195	CcSEcCtD
Perhexiline—Loss of consciousness—Paclitaxel—kidney cancer	0.000408	0.00195	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—kidney cancer	0.000408	0.00195	CcSEcCtD
Perhexiline—Paraesthesia—Gemcitabine—kidney cancer	0.000406	0.00194	CcSEcCtD
Perhexiline—Flushing—Capecitabine—kidney cancer	0.000406	0.00194	CcSEcCtD
Perhexiline—Asthenia—Sunitinib—kidney cancer	0.000405	0.00193	CcSEcCtD
Perhexiline—Nausea—Vinblastine—kidney cancer	0.000403	0.00192	CcSEcCtD
Perhexiline—Convulsion—Paclitaxel—kidney cancer	0.000402	0.00192	CcSEcCtD
Perhexiline—Nausea—Everolimus—kidney cancer	0.000401	0.00191	CcSEcCtD
Perhexiline—Decreased appetite—Gemcitabine—kidney cancer	0.000393	0.00188	CcSEcCtD
Perhexiline—Fatigue—Gemcitabine—kidney cancer	0.00039	0.00186	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vincristine—kidney cancer	0.00039	0.00186	CcSEcCtD
Perhexiline—Dizziness—Sorafenib—kidney cancer	0.000388	0.00185	CcSEcCtD
Perhexiline—Nausea—Erlotinib—kidney cancer	0.000387	0.00185	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—kidney cancer	0.000383	0.00183	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—kidney cancer	0.000383	0.00183	CcSEcCtD
Perhexiline—Abdominal pain—Vincristine—kidney cancer	0.000377	0.0018	CcSEcCtD
Perhexiline—Dizziness—Sunitinib—kidney cancer	0.000373	0.00178	CcSEcCtD
Perhexiline—Shock—Paclitaxel—kidney cancer	0.000373	0.00178	CcSEcCtD
Perhexiline—Vomiting—Sorafenib—kidney cancer	0.000373	0.00178	CcSEcCtD
Perhexiline—Rash—Sorafenib—kidney cancer	0.00037	0.00176	CcSEcCtD
Perhexiline—Dermatitis—Sorafenib—kidney cancer	0.000369	0.00176	CcSEcCtD
Perhexiline—Headache—Sorafenib—kidney cancer	0.000367	0.00175	CcSEcCtD
Perhexiline—Hyperhidrosis—Paclitaxel—kidney cancer	0.000366	0.00175	CcSEcCtD
Perhexiline—Anorexia—Paclitaxel—kidney cancer	0.000361	0.00172	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—kidney cancer	0.00036	0.00172	CcSEcCtD
Perhexiline—Vomiting—Sunitinib—kidney cancer	0.000359	0.00171	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—ACY1—kidney cancer	0.000357	0.00353	CbGpPWpGaD
Perhexiline—Tremor—Capecitabine—kidney cancer	0.000357	0.0017	CcSEcCtD
Perhexiline—Rash—Sunitinib—kidney cancer	0.000356	0.0017	CcSEcCtD
Perhexiline—Dermatitis—Sunitinib—kidney cancer	0.000355	0.0017	CcSEcCtD
Perhexiline—Headache—Sunitinib—kidney cancer	0.000353	0.00169	CcSEcCtD
Perhexiline—Nausea—Sorafenib—kidney cancer	0.000348	0.00166	CcSEcCtD
Perhexiline—CPT2—Metabolism—APRT—kidney cancer	0.000346	0.00341	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—FH—kidney cancer	0.000346	0.00341	CbGpPWpGaD
Perhexiline—Insomnia—Paclitaxel—kidney cancer	0.000343	0.00164	CcSEcCtD
Perhexiline—Asthenia—Vincristine—kidney cancer	0.000342	0.00163	CcSEcCtD
Perhexiline—Syncope—Capecitabine—kidney cancer	0.000342	0.00163	CcSEcCtD
Perhexiline—Paraesthesia—Paclitaxel—kidney cancer	0.00034	0.00162	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—kidney cancer	0.00034	0.00162	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000338	0.00334	CbGpPWpGaD
Perhexiline—Rash—Dactinomycin—kidney cancer	0.000337	0.00161	CcSEcCtD
Perhexiline—Nausea—Sunitinib—kidney cancer	0.000335	0.0016	CcSEcCtD
Perhexiline—Loss of consciousness—Capecitabine—kidney cancer	0.000335	0.0016	CcSEcCtD
Perhexiline—Decreased appetite—Paclitaxel—kidney cancer	0.000329	0.00157	CcSEcCtD
Perhexiline—Fatigue—Paclitaxel—kidney cancer	0.000327	0.00156	CcSEcCtD
Perhexiline—CPT2—Metabolism—GPC3—kidney cancer	0.000325	0.00321	CbGpPWpGaD
Perhexiline—Asthenia—Gemcitabine—kidney cancer	0.000325	0.00155	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—kidney cancer	0.000321	0.00317	CbGpPWpGaD
Perhexiline—Weight decreased—Doxorubicin—kidney cancer	0.000319	0.00152	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—kidney cancer	0.000317	0.00151	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000317	0.00313	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PDHB—kidney cancer	0.000316	0.00312	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CA2—kidney cancer	0.000316	0.00312	CbGpPWpGaD
Perhexiline—Dizziness—Vincristine—kidney cancer	0.000315	0.00151	CcSEcCtD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000314	0.00311	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—kidney cancer	0.000311	0.00307	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00031	0.00148	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000308	0.00147	CcSEcCtD
Perhexiline—CPT2—Metabolism—ALAD—kidney cancer	0.000308	0.00304	CbGpPWpGaD
Perhexiline—Shock—Capecitabine—kidney cancer	0.000306	0.00146	CcSEcCtD
Perhexiline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000304	0.003	CbGpPWpGaD
Perhexiline—Vomiting—Vincristine—kidney cancer	0.000303	0.00145	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—kidney cancer	0.000301	0.00144	CcSEcCtD
Perhexiline—Urticaria—Paclitaxel—kidney cancer	0.000301	0.00144	CcSEcCtD
Perhexiline—Rash—Vincristine—kidney cancer	0.000301	0.00144	CcSEcCtD
Perhexiline—CPT2—Metabolism—ST3GAL2—kidney cancer	0.000301	0.00297	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Capecitabine—kidney cancer	0.000301	0.00144	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—kidney cancer	0.000301	0.00143	CcSEcCtD
Perhexiline—Abdominal pain—Paclitaxel—kidney cancer	0.0003	0.00143	CcSEcCtD
Perhexiline—Headache—Vincristine—kidney cancer	0.000299	0.00143	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CCBL1—kidney cancer	0.000297	0.00294	CbGpPWpGaD
Perhexiline—Anorexia—Capecitabine—kidney cancer	0.000296	0.00142	CcSEcCtD
Perhexiline—CPT2—Metabolism—ALDH1A1—kidney cancer	0.000294	0.0029	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000292	0.00289	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000292	0.00288	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000289	0.00285	CbGpPWpGaD
Perhexiline—Vomiting—Gemcitabine—kidney cancer	0.000288	0.00137	CcSEcCtD
Perhexiline—Rash—Gemcitabine—kidney cancer	0.000285	0.00136	CcSEcCtD
Perhexiline—Dermatitis—Gemcitabine—kidney cancer	0.000285	0.00136	CcSEcCtD
Perhexiline—Headache—Gemcitabine—kidney cancer	0.000284	0.00135	CcSEcCtD
Perhexiline—Nausea—Vincristine—kidney cancer	0.000283	0.00135	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—kidney cancer	0.000282	0.00135	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—ALDH1A1—kidney cancer	0.000282	0.00278	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC5A3—kidney cancer	0.000282	0.00278	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PGK1—kidney cancer	0.000282	0.00278	CbGpPWpGaD
Perhexiline—Insomnia—Capecitabine—kidney cancer	0.000281	0.00134	CcSEcCtD
Perhexiline—Paraesthesia—Capecitabine—kidney cancer	0.000279	0.00133	CcSEcCtD
Perhexiline—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000276	0.00273	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—LDHB—kidney cancer	0.000276	0.00273	CbGpPWpGaD
Perhexiline—Asthenia—Paclitaxel—kidney cancer	0.000272	0.0013	CcSEcCtD
Perhexiline—Decreased appetite—Capecitabine—kidney cancer	0.00027	0.00129	CcSEcCtD
Perhexiline—Nausea—Gemcitabine—kidney cancer	0.000269	0.00128	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000269	0.00266	CbGpPWpGaD
Perhexiline—Fatigue—Capecitabine—kidney cancer	0.000268	0.00128	CcSEcCtD
Perhexiline—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000265	0.00262	CbGpPWpGaD
Perhexiline—Flushing—Doxorubicin—kidney cancer	0.000262	0.00125	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GLIPR1—kidney cancer	0.000258	0.00255	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPAT—kidney cancer	0.000258	0.00255	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000254	0.00251	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Capecitabine—kidney cancer	0.000254	0.00121	CcSEcCtD
Perhexiline—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000254	0.00251	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000252	0.00249	CbGpPWpGaD
Perhexiline—Dizziness—Paclitaxel—kidney cancer	0.000251	0.0012	CcSEcCtD
Perhexiline—Urticaria—Capecitabine—kidney cancer	0.000247	0.00118	CcSEcCtD
Perhexiline—Abdominal pain—Capecitabine—kidney cancer	0.000246	0.00117	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000245	0.00242	CbGpPWpGaD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000244	0.00241	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000243	0.0024	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000241	0.00238	CbGpPWpGaD
Perhexiline—Tension—Doxorubicin—kidney cancer	0.000241	0.00115	CcSEcCtD
Perhexiline—Vomiting—Paclitaxel—kidney cancer	0.000241	0.00115	CcSEcCtD
Perhexiline—CPT2—Metabolism—CA9—kidney cancer	0.00024	0.00237	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—FH—kidney cancer	0.00024	0.00237	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—APRT—kidney cancer	0.00024	0.00237	CbGpPWpGaD
Perhexiline—Rash—Paclitaxel—kidney cancer	0.000239	0.00114	CcSEcCtD
Perhexiline—Dermatitis—Paclitaxel—kidney cancer	0.000239	0.00114	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—kidney cancer	0.000239	0.00114	CcSEcCtD
Perhexiline—Headache—Paclitaxel—kidney cancer	0.000237	0.00113	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000234	0.00231	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000234	0.00231	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000234	0.00231	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000232	0.00229	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000229	0.00226	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GPC3—kidney cancer	0.000225	0.00223	CbGpPWpGaD
Perhexiline—Nausea—Paclitaxel—kidney cancer	0.000225	0.00107	CcSEcCtD
Perhexiline—Asthenia—Capecitabine—kidney cancer	0.000223	0.00107	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—kidney cancer	0.00022	0.00105	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CA2—kidney cancer	0.000219	0.00216	CbGpPWpGaD
Perhexiline—Loss of consciousness—Doxorubicin—kidney cancer	0.000216	0.00103	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000214	0.00211	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALAD—kidney cancer	0.000213	0.00211	CbGpPWpGaD
Perhexiline—Convulsion—Doxorubicin—kidney cancer	0.000213	0.00102	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ST3GAL2—kidney cancer	0.000208	0.00206	CbGpPWpGaD
Perhexiline—Dizziness—Capecitabine—kidney cancer	0.000206	0.000982	CcSEcCtD
Perhexiline—CPT2—Metabolism—CRABP1—kidney cancer	0.000204	0.00201	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALDH1A1—kidney cancer	0.000204	0.00201	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000203	0.00201	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—JUN—kidney cancer	0.0002	0.00198	CbGpPWpGaD
Perhexiline—Vomiting—Capecitabine—kidney cancer	0.000198	0.000944	CcSEcCtD
Perhexiline—Shock—Doxorubicin—kidney cancer	0.000197	0.000941	CcSEcCtD
Perhexiline—Rash—Capecitabine—kidney cancer	0.000196	0.000936	CcSEcCtD
Perhexiline—Dermatitis—Capecitabine—kidney cancer	0.000196	0.000935	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000196	0.00194	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC5A3—kidney cancer	0.000195	0.00193	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PGK1—kidney cancer	0.000195	0.00193	CbGpPWpGaD
Perhexiline—Headache—Capecitabine—kidney cancer	0.000195	0.00093	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—kidney cancer	0.000194	0.000925	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—kidney cancer	0.000193	0.00191	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—LDHB—kidney cancer	0.000191	0.00189	CbGpPWpGaD
Perhexiline—Anorexia—Doxorubicin—kidney cancer	0.000191	0.000912	CcSEcCtD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00019	0.00187	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ITPR2—kidney cancer	0.000189	0.00187	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000188	0.00186	CbGpPWpGaD
Perhexiline—Nausea—Capecitabine—kidney cancer	0.000185	0.000882	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—kidney cancer	0.000181	0.000866	CcSEcCtD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000181	0.00178	CbGpPWpGaD
Perhexiline—Paraesthesia—Doxorubicin—kidney cancer	0.00018	0.000859	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000175	0.00172	CbGpPWpGaD
Perhexiline—Decreased appetite—Doxorubicin—kidney cancer	0.000174	0.000832	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000173	0.00171	CbGpPWpGaD
Perhexiline—Fatigue—Doxorubicin—kidney cancer	0.000173	0.000825	CcSEcCtD
Perhexiline—CPT2—Metabolism—GSTT1—kidney cancer	0.000173	0.00171	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ACHE—kidney cancer	0.000173	0.00171	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CA9—kidney cancer	0.000166	0.00164	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTT1—kidney cancer	0.000166	0.00164	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000164	0.000783	CcSEcCtD
Perhexiline—CPT2—Metabolism—SCARB1—kidney cancer	0.000163	0.00161	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000162	0.0016	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS1—kidney cancer	0.000162	0.0016	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000161	0.00159	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000159	0.00157	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—kidney cancer	0.000159	0.00076	CcSEcCtD
Perhexiline—CPT2—Metabolism—PSMD7—kidney cancer	0.000159	0.00157	CbGpPWpGaD
Perhexiline—Abdominal pain—Doxorubicin—kidney cancer	0.000158	0.000756	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—PTGS1—kidney cancer	0.000155	0.00153	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BCHE—kidney cancer	0.00015	0.00149	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC5A5—kidney cancer	0.000149	0.00147	CbGpPWpGaD
Perhexiline—Asthenia—Doxorubicin—kidney cancer	0.000144	0.000687	CcSEcCtD
Perhexiline—CPT2—Metabolism—SLC2A1—kidney cancer	0.000143	0.00142	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CRABP1—kidney cancer	0.000141	0.00139	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00014	0.00139	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000139	0.00138	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000133	0.00131	CbGpPWpGaD
Perhexiline—Dizziness—Doxorubicin—kidney cancer	0.000133	0.000633	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—kidney cancer	0.000132	0.0013	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ITPR2—kidney cancer	0.000131	0.0013	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000131	0.00129	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000131	0.00129	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000128	0.00127	CbGpPWpGaD
Perhexiline—Vomiting—Doxorubicin—kidney cancer	0.000127	0.000608	CcSEcCtD
Perhexiline—Rash—Doxorubicin—kidney cancer	0.000126	0.000603	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—kidney cancer	0.000126	0.000603	CcSEcCtD
Perhexiline—Headache—Doxorubicin—kidney cancer	0.000126	0.000599	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000121	0.0012	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000121	0.0012	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.00012	0.00119	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ACHE—kidney cancer	0.00012	0.00118	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTP1—kidney cancer	0.00012	0.00118	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTT1—kidney cancer	0.00012	0.00118	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—kidney cancer	0.000119	0.000568	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—kidney cancer	0.000115	0.00114	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—kidney cancer	0.000115	0.00113	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SCARB1—kidney cancer	0.000113	0.00112	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—kidney cancer	0.000113	0.00112	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—kidney cancer	0.000113	0.00112	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS1—kidney cancer	0.000112	0.00111	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PSMD7—kidney cancer	0.00011	0.00109	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTM1—kidney cancer	0.00011	0.00109	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—PTGS1—kidney cancer	0.000108	0.00107	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000106	0.00104	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTM1—kidney cancer	0.000105	0.00104	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BCHE—kidney cancer	0.000104	0.00103	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP1A1—kidney cancer	0.000104	0.00103	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000104	0.00103	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTM1—kidney cancer	0.000104	0.00103	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC5A5—kidney cancer	0.000103	0.00102	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP1A1—kidney cancer	0.0001	0.000988	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC2A1—kidney cancer	9.95e-05	0.000983	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP1A1—kidney cancer	9.86e-05	0.000974	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.76e-05	0.000964	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.65e-05	0.000954	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ACY1—kidney cancer	8.8e-05	0.000869	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.57e-05	0.000846	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.55e-05	0.000845	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.42e-05	0.000832	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—kidney cancer	8.3e-05	0.00082	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—kidney cancer	7.98e-05	0.000788	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	7.87e-05	0.000777	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.87e-05	0.000777	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—kidney cancer	7.85e-05	0.000776	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—POMC—kidney cancer	7.77e-05	0.000768	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTM1—kidney cancer	7.62e-05	0.000753	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—kidney cancer	7.53e-05	0.000744	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PDHB—kidney cancer	7.48e-05	0.000739	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—POMC—kidney cancer	7.46e-05	0.000737	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTM1—kidney cancer	7.33e-05	0.000724	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	7.23e-05	0.000714	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP1A1—kidney cancer	7.23e-05	0.000714	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.05e-05	0.000697	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CCBL1—kidney cancer	7.03e-05	0.000695	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	6.95e-05	0.000687	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	6.85e-05	0.000677	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.38e-05	0.00063	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—kidney cancer	6.2e-05	0.000613	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACY1—kidney cancer	6.11e-05	0.000604	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GLIPR1—kidney cancer	6.1e-05	0.000602	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPAT—kidney cancer	6.1e-05	0.000602	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.94e-05	0.000587	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FH—kidney cancer	5.67e-05	0.00056	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APRT—kidney cancer	5.67e-05	0.00056	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—kidney cancer	5.41e-05	0.000534	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—POMC—kidney cancer	5.39e-05	0.000532	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPC3—kidney cancer	5.33e-05	0.000527	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.22e-05	0.000515	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PDHB—kidney cancer	5.2e-05	0.000514	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA2—kidney cancer	5.18e-05	0.000512	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—POMC—kidney cancer	5.18e-05	0.000512	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.14e-05	0.000508	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALAD—kidney cancer	5.05e-05	0.000499	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ST3GAL2—kidney cancer	4.93e-05	0.000487	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CCBL1—kidney cancer	4.89e-05	0.000483	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALDH1A1—kidney cancer	4.82e-05	0.000476	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.79e-05	0.000474	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.73e-05	0.000467	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PGK1—kidney cancer	4.62e-05	0.000457	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC5A3—kidney cancer	4.62e-05	0.000457	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.54e-05	0.000449	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—LDHB—kidney cancer	4.53e-05	0.000448	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.48e-05	0.000443	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—kidney cancer	4.3e-05	0.000425	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GLIPR1—kidney cancer	4.24e-05	0.000419	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPAT—kidney cancer	4.24e-05	0.000419	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACY1—kidney cancer	4e-05	0.000395	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FH—kidney cancer	3.94e-05	0.000389	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APRT—kidney cancer	3.94e-05	0.000389	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA9—kidney cancer	3.93e-05	0.000388	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—kidney cancer	3.81e-05	0.000377	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—kidney cancer	3.75e-05	0.00037	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPC3—kidney cancer	3.7e-05	0.000366	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA2—kidney cancer	3.6e-05	0.000356	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALAD—kidney cancer	3.51e-05	0.000347	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ST3GAL2—kidney cancer	3.43e-05	0.000339	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PDHB—kidney cancer	3.4e-05	0.000336	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—POMC—kidney cancer	3.39e-05	0.000335	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALDH1A1—kidney cancer	3.35e-05	0.000331	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CRABP1—kidney cancer	3.34e-05	0.00033	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PGK1—kidney cancer	3.21e-05	0.000317	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC5A3—kidney cancer	3.21e-05	0.000317	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CCBL1—kidney cancer	3.2e-05	0.000316	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LDHB—kidney cancer	3.15e-05	0.000311	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ITPR2—kidney cancer	3.11e-05	0.000307	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ACHE—kidney cancer	2.83e-05	0.00028	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—kidney cancer	2.83e-05	0.00028	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.77e-05	0.000274	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPAT—kidney cancer	2.77e-05	0.000274	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA9—kidney cancer	2.73e-05	0.00027	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SCARB1—kidney cancer	2.68e-05	0.000265	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS1—kidney cancer	2.65e-05	0.000262	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—kidney cancer	2.64e-05	0.000261	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PSMD7—kidney cancer	2.6e-05	0.000257	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FH—kidney cancer	2.58e-05	0.000254	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APRT—kidney cancer	2.58e-05	0.000254	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BCHE—kidney cancer	2.47e-05	0.000244	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC5A5—kidney cancer	2.44e-05	0.000241	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPC3—kidney cancer	2.42e-05	0.000239	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA2—kidney cancer	2.36e-05	0.000233	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.35e-05	0.000233	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CRABP1—kidney cancer	2.32e-05	0.000229	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALAD—kidney cancer	2.3e-05	0.000227	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.24e-05	0.000221	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.19e-05	0.000216	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ITPR2—kidney cancer	2.16e-05	0.000213	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PGK1—kidney cancer	2.1e-05	0.000207	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.1e-05	0.000207	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LDHB—kidney cancer	2.06e-05	0.000203	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—kidney cancer	1.97e-05	0.000194	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACHE—kidney cancer	1.97e-05	0.000194	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—kidney cancer	1.96e-05	0.000194	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SCARB1—kidney cancer	1.86e-05	0.000184	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—kidney cancer	1.86e-05	0.000184	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS1—kidney cancer	1.84e-05	0.000182	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PSMD7—kidney cancer	1.81e-05	0.000179	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—kidney cancer	1.8e-05	0.000178	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA9—kidney cancer	1.79e-05	0.000176	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BCHE—kidney cancer	1.71e-05	0.000169	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.71e-05	0.000169	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.69e-05	0.000167	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000162	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CRABP1—kidney cancer	1.52e-05	0.00015	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ITPR2—kidney cancer	1.41e-05	0.000139	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—kidney cancer	1.36e-05	0.000135	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACHE—kidney cancer	1.29e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—kidney cancer	1.29e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—POMC—kidney cancer	1.28e-05	0.000126	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—kidney cancer	1.25e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SCARB1—kidney cancer	1.22e-05	0.00012	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS1—kidney cancer	1.21e-05	0.000119	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000117	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSMD7—kidney cancer	1.18e-05	0.000117	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BCHE—kidney cancer	1.12e-05	0.000111	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.11e-05	0.000109	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.07e-05	0.000106	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—kidney cancer	1.02e-05	0.0001	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—kidney cancer	8.92e-06	8.81e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—kidney cancer	8.87e-06	8.76e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—POMC—kidney cancer	8.86e-06	8.76e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—kidney cancer	8.44e-06	8.34e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—kidney cancer	8.2e-06	8.1e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.77e-06	7.68e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—kidney cancer	7.07e-06	6.98e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—kidney cancer	6.26e-06	6.18e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—kidney cancer	6.16e-06	6.09e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—POMC—kidney cancer	5.79e-06	5.72e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—kidney cancer	4.62e-06	4.57e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—kidney cancer	4.35e-06	4.3e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—kidney cancer	4.03e-06	3.98e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.84e-06	2.81e-05	CbGpPWpGaD
